{"id":"nitrefazole","rwe":[{"pmid":"29802284","year":"2018","title":"High-throughput screening identified selective inhibitors of exosome biogenesis and secretion: A drug repurposing strategy for advanced cancer.","finding":"","journal":"Scientific reports","studyType":"Clinical Study"},{"pmid":"2310412","year":"1990","title":"Differences in the kinetic properties and sensitivity to inhibitors of human placental, erythrocyte, and major hepatic aldehyde dehydrogenase isoenzymes.","finding":"","journal":"Biochemical pharmacology","studyType":"Clinical Study"},{"pmid":"3893193","year":"1985","title":"The nitrefazole-ethanol interaction in man: cardiovascular responses and the accumulation of acetaldehyde and catecholamines.","finding":"","journal":"Alcoholism, clinical and experimental research","studyType":"Clinical Study"},{"pmid":"4074438","year":"1985","title":"[Nitrefazole, a 4-nitroimidazole derivative with a marked inhibitory effect on aldehyde dehydrogenase. Synthesis and structural assignment].","finding":"","journal":"Arzneimittel-Forschung","studyType":"Clinical Study"},{"pmid":"6598964","year":"1984","title":"The impact of a new alcohol sensitizing agent (nitrefazole) on craving in severely dependent alcoholics.","finding":"","journal":"British journal of addiction","studyType":"Clinical Study"}],"tags":[{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"marketed","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=NITREFAZOLE","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T02:00:48.925284+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T02:00:54.193540+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=NITREFAZOLE","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T02:00:54.434067+00:00"},"mechanism.target_chembl":{"url":"","method":"api_direct","source":"ChEMBL mechanism: Alcohol dehydrogenase inhibitor","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T02:00:55.456949+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1909285/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T02:00:55.124957+00:00"}},"allNames":"altimol","offLabel":[],"synonyms":["nitrefazole","altimol"],"timeline":[],"approvals":[],"brandName":"Altimol","ecosystem":[],"mechanism":{"modality":"Small Molecule","explanation":"","oneSentence":"","technicalDetail":"Altimol's exact mechanism of action is unknown, but it is likely to involve the inhibition of a specific enzyme or protein that plays a key role in cellular processes."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/1946","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=NITREFAZOLE","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T12:59:19.341934","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T02:00:56.643332+00:00","fieldsConflicting":1,"overallConfidence":0.8},"biosimilars":[],"competitors":[],"genericName":"nitrefazole","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"VFD629099M","CHEBI":"CHEBI:135009","INN_ID":"5031","UMLSCUI":"C0068807","chemblId":"CHEMBL1909285","ChEMBL_ID":"CHEMBL1909285","PUBCHEM_CID":"71900","MESH_SUPPLEMENTAL_RECORD_UI":"C013756"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":7,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[{"date":"2018 May 25","pmid":"29802284","title":"High-throughput screening identified selective inhibitors of exosome biogenesis and secretion: A drug repurposing strategy for advanced cancer.","journal":"Scientific reports"},{"date":"1990 Mar 1","pmid":"2310412","title":"Differences in the kinetic properties and sensitivity to inhibitors of human placental, erythrocyte, and major hepatic aldehyde dehydrogenase isoenzymes.","journal":"Biochemical pharmacology"},{"date":"1985 May-Jun","pmid":"3893193","title":"The nitrefazole-ethanol interaction in man: cardiovascular responses and the accumulation of acetaldehyde and catecholamines.","journal":"Alcoholism, clinical and experimental research"},{"date":"1985","pmid":"4074438","title":"[Nitrefazole, a 4-nitroimidazole derivative with a marked inhibitory effect on aldehyde dehydrogenase. Synthesis and structural assignment].","journal":"Arzneimittel-Forschung"},{"date":"1984 Dec","pmid":"6598964","title":"The impact of a new alcohol sensitizing agent (nitrefazole) on craving in severely dependent alcoholics.","journal":"British journal of addiction"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"withdrawn","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T02:00:56.643332+00:00","fieldsConflicting":1,"overallConfidence":0.8},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":false,"safety":false,"trials":false,"score":0}}